Gowlings Logo Life Sciences News @ Gowlings
August 7, 2012

Life Sciences News @ Gowlings image
  Use Twitter?    Follow Gowlings news on Twitter

Disappointment as Pfizer/J&J AD drug fails another trial

Merck's Singulair surrenders to generics posse

Novartis signs cancer immunotherapy pact with Penn

Mylan launches 18 HIV drugs in India

Teva is latest drugmaker to face foreign bribe probe

Zaltrap approval a win for Sanofi, even at $400M max

AstraZeneca faces fresh questions over MedImmune deal

Astellas Pharma axes Durham R&D site amid generics threat

Sick health care system made Canadians lose more than $3-billion in economic activity in 2011: Fraser Institute

Man texts 'I need to quit texting' then drives off bridge

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

© 2012 Gowling Lafleur Henderson LLP. All rights reserved.